Type II diabetes, glucose "non-sense," and islet desensitization - PubMed (original) (raw)
Review
. 1989 Dec;38(12):1501-5.
doi: 10.2337/diab.38.12.1501.
Affiliations
- PMID: 2684709
- DOI: 10.2337/diab.38.12.1501
Review
Type II diabetes, glucose "non-sense," and islet desensitization
R P Robertson. Diabetes. 1989 Dec.
Abstract
A universal finding in hyperglycemic patients with type II (non-insulin-dependent) diabetes mellitus is that all share a common defect in glucose recognition resulting in abnormal insulin secretion by pancreatic islet beta-cells. This defect is 1) specific for glucose signals rather than global, 2) related to chronic hyperglycemia, and 3) partially reversible after brief treatment with insulin to induce normoglycemia and through use of other pharmacological agents without normalizing glucose levels. My perspective is that an essential component of this defect is secondary and may represent a state of homologous desensitization of the beta-cell secretory apparatus to glucose. Elucidation of the biochemical mechanism(s) of defective recognition of glucose signals by beta-cells--or glucose "non-sense"--in these patients will provide key insights into the pathogenesis of type II diabetes mellitus.
Similar articles
- Islet dysfunction in non-insulin-dependent diabetes mellitus.
Kahn SE, Porte D Jr. Kahn SE, et al. Am J Med. 1988 Nov 28;85(5A):4-8. doi: 10.1016/0002-9343(88)90392-0. Am J Med. 1988. PMID: 3057894 Review. - Banting lecture 1990. Beta-cells in type II diabetes mellitus.
Porte D Jr. Porte D Jr. Diabetes. 1991 Feb;40(2):166-80. doi: 10.2337/diab.40.2.166. Diabetes. 1991. PMID: 1991568 Review. - Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
Nesher R, Warwar N, Khan A, Efendic S, Cerasi E, Kaiser N. Nesher R, et al. Diabetes. 2001 Feb;50(2):308-14. doi: 10.2337/diabetes.50.2.308. Diabetes. 2001. PMID: 11272141 - Type II diabetes mellitus.
Edelman SV. Edelman SV. Adv Intern Med. 1998;43:449-500. Adv Intern Med. 1998. PMID: 9506190 Review. - Defective insulin secretion in NIDDM: integral part of a multiplier hypothesis.
Robertson RP. Robertson RP. J Cell Biochem. 1992 Mar;48(3):227-33. doi: 10.1002/jcb.240480302. J Cell Biochem. 1992. PMID: 1400609 Review.
Cited by
- Hexosamine pathway but not interstitial changes mediates glucotoxicity in pancreatic β-cells as assessed by cytosolic Ca2+ response to glucose.
Yanagida K, Maejima Y, Santoso P, Otgon-Uul Z, Yang Y, Sakuma K, Shimomura K, Yada T. Yanagida K, et al. Aging (Albany NY). 2014 Mar;6(3):207-14. doi: 10.18632/aging.100647. Aging (Albany NY). 2014. PMID: 24704640 Free PMC article. - Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15.
Moran A, Zhang HJ, Olson LK, Harmon JS, Poitout V, Robertson RP. Moran A, et al. J Clin Invest. 1997 Feb 1;99(3):534-9. doi: 10.1172/JCI119190. J Clin Invest. 1997. PMID: 9022089 Free PMC article. - Metabolomics applied to the pancreatic islet.
Gooding JR, Jensen MV, Newgard CB. Gooding JR, et al. Arch Biochem Biophys. 2016 Jan 1;589:120-30. doi: 10.1016/j.abb.2015.06.013. Epub 2015 Jun 25. Arch Biochem Biophys. 2016. PMID: 26116790 Free PMC article. Review. - A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity.
Tanaka Y, Tran PO, Harmon J, Robertson RP. Tanaka Y, et al. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12363-8. doi: 10.1073/pnas.192445199. Epub 2002 Sep 6. Proc Natl Acad Sci U S A. 2002. PMID: 12218186 Free PMC article. - Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.
Ling Z, Pipeleers DG. Ling Z, et al. J Clin Invest. 1996 Dec 15;98(12):2805-12. doi: 10.1172/JCI119108. J Clin Invest. 1996. PMID: 8981928 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical